Discover

CRBP
Corbus Pharmaceuticals Holdings, Inc.
9.07
1 x 8.80
1 x 10.44
bid
ask
-
0.31
3.30%
1 @ 04:41 AM
9.21 +0.14 (1.54%)
Ytd11.43%
1y26.68%
8.99
day range
9.45
7.12
52 week range
20.56
Open9.29Prev Close9.38Low8.99High9.45Mkt Cap168.05M
Vol441.38KAvg Vol485.48KEPS-5.74P/EN/AForward P/E-2.51
Beta2.56Short Ratio8.28Inst. Own105.21%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1150-d Avg9.29200-d Avg10.191yr Est56.78

CRBP News

benzinga.com
Mizuho Maintains Outperform on Corbus Pharmaceuticals, Lowers Price Target to $34

Mizuho analyst Graig Suvannavejh maintains Corbus Pharmaceuticals (NASDAQ:CRBP) with a Outperform

benzinga.com
Oppenheimer Maintains Outperform on Corbus Pharmaceuticals, Lowers Price Target to $52

Oppenheimer analyst Jeff Jones maintains Corbus Pharmaceuticals (NASDAQ:CRBP) with a Outperform a

benzinga.com
Wedbush Maintains Outperform on Corbus Pharmaceuticals, Lowers Price Target to $30

Wedbush analyst Robert Driscoll maintains Corbus Pharmaceuticals (NASDAQ:CRBP) with a Outperform

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

benzinga.com
HC Wainwright & Co. Reiterates Buy on Corbus Pharmaceuticals, Maintains $40 Price Target

HC Wainwright & Co. analyst Andres Y. Maldonado reiterates Corbus Pharmaceuticals (NASDAQ:CRB

benzinga.com
Corbus Pharma Reports Updated Data From Phase 1/2 Clinical Study Of CRB-701, Next-Gen Nectin-4 Targe

Data affirms Corbus strategy of targeting tumor types with elevated Nectin-4 expression and clear un

benzinga.com
Mizuho Maintains Outperform on Corbus Pharmaceuticals, Raises Price Target to $44

Mizuho analyst Graig Suvannavejh maintains Corbus Pharmaceuticals (NASDAQ:CRBP) with a Outperform

benzinga.com
Corbus Pharmaceuticals To Discuss Updated Data For Its Phase 1/2 Trial Of CRB-701 Antibody Drug Cand

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), a clinical-stage company focused on developing

benzinga.com
Jefferies Maintains Buy on Corbus Pharmaceuticals, Lowers Price Target to $33

Jefferies analyst Maury Raycroft maintains Corbus Pharmaceuticals (NASDAQ:CRBP) with a Buy and lo

benzinga.com
Oppenheimer Maintains Outperform on Corbus Pharmaceuticals, Lowers Price Target to $54

Oppenheimer analyst Jeff Jones maintains Corbus Pharmaceuticals (NASDAQ:CRBP) with a Outperform a

benzinga.com
Guggenheim Reiterates Buy on Corbus Pharmaceuticals, Maintains $45 Price Target

Guggenheim analyst Paul Jeng reiterates Corbus Pharmaceuticals (NASDAQ:CRBP) with a Buy and maint

benzinga.com
Corbus Pharmaceuticals Q1 EPS $(1.23) Misses $(1.22) Estimate

Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(1.23) per share which missed the

benzinga.com
Guggenheim Initiates Coverage On Corbus Pharmaceuticals with Buy Rating, Announces Price Target of $

Guggenheim analyst Paul Jeng initiates coverage on Corbus Pharmaceuticals (NASDAQ:CRBP) with a Bu

benzinga.com
Corbus Pharmaceuticals Doses Last Participant In Its CANYON-1 Phase 1b Clinical Study Of CRB-913 To

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a clinical-stage company focused on promising

Corbus Offers Upside Despite Post-FDA Update, Analyst Highlights Competitive Edge
benzinga.com
Corbus Offers Upside Despite Post-FDA Update, Analyst Highlights Competitive Edge

Corbus reports FDA alignment on the CRB-701 path, as analysts flag upside tied to the head and neck

benzinga.com
Corbus Secures FDA Alignment On CRB-701 Registrational Studies For HNSCC And Cervical Cancer; Update

FDA feedback enables Corbus to proceed with proposed registrational study design and endpoints to su

benzinga.com
Oppenheimer Maintains Outperform on Corbus Pharmaceuticals, Raises Price Target to $57

Oppenheimer analyst Jeff Jones maintains Corbus Pharmaceuticals (NASDAQ:CRBP) with a Outperform a

Corbus Pharmaceuticals Q4 Earnings Summary & Key Takeaways
benzinga.com
Corbus Pharmaceuticals Q4 Earnings Summary & Key Takeaways

benzinga.com
Corbus Pharmaceuticals Q4 EPS $(1.25) Beats $(1.38) Estimate

Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(1.25) per share which beat the a

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

benzinga.com
Corbus Pharmaceuticals Highlights Safe, Well-Tolerated CRB-913 Phase 1a Results With Emerging Eviden

CRB-913 was safe and well-tolerated across all doses studiedDaily neuropsychiatric assessments using

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

benzinga.com
Corbus Pharmaceuticals To Release Phase 1a Results For Obesity Drug CRB-913 On December 11, 2025

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP), a clinical stage company focused on oncology and

benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

Roku, SPS Commerce, Newell Brands And Other Big Stocks Moving Lower In Friday's Pre-Market Session
benzinga.com
Roku, SPS Commerce, Newell Brands And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Why Amazon Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Amazon Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket

benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session

benzinga.com
Cannabis Stock Gainers And Losers From July 16, 2025

benzinga.com
Cannabis Stock Movers For July 15, 2025

benzinga.com
Bullish Sentiment Across The Cannabis Space - Check Full Movers For July 9, 2025

benzinga.com
Marijuana Stock Movers For July 2, 2025

benzinga.com
Cannabis Stock Movers For June 30, 2025

benzinga.com
Cannabis Stock Movers For June 27, 2025

benzinga.com
Cannabis Stock Gainers And Losers From June 26, 2025

benzinga.com
Cannabis Stock Gainers And Losers From June 25, 2025

benzinga.com
Marijuana Stock Movers For June 17, 2025

benzinga.com
Cannabis Stock Gainers And Losers From June 13, 2025

benzinga.com
Marijuana Stock Movers For May 8, 2025

benzinga.com
Cannabis Stock Gainers And Losers From May 6, 2025

benzinga.com
Cannabis Stock Movers For April 24, 2025

benzinga.com
Cannabis Stock Gainers And Losers From April 8, 2025

benzinga.com
Bullish Sentiment Across The Cannabis Space - Check Full Movers For April 1, 2025

benzinga.com
Marijuana Stock Movers For March 24, 2025

benzinga.com
Cannabis Stock Gainers And Losers From October 1, 2024

benzinga.com
Cannabis Stock Movers For September 25, 2024

benzinga.com
Bullish Sentiment Across The Cannabis Space - Check Full Movers For September 19, 2024

benzinga.com
Cannabis Stocks React To Trump's Marijuana Comments: See Which Ones Posted Solid Gains

Trump confirmed his support for recreational cannabis in Florida. and sparked a reaction in the cann

benzinga.com
Marijuana Stock Movers For September 9, 2024

benzinga.com
Marijuana Stock Movers For September 3, 2024